Baird Financial Group, Inc.
- SEC CIK
- 0001648711
- Latest filing
- Aug 12, 2026
EDIT holding history
Editas Medicine, Inc. in every 13F filed by Baird Financial Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EDIT overviewAll 13F holders of EDITFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −10,169−100.0% | Sold out | Holders |
| Q1 2026 | 10,169 | $25.1K | <0.1% | −10,701−51.3% | Reduced | Holders |
| Q4 2025 | 20,870 | $42.8K | <0.1% | −7,672−26.9% | Reduced | Holders |
| Q3 2025 | 28,542 | $99.0K | <0.1% | −329−1.1% | Reduced | Holders |
| Q2 2025 | 28,871 | $63.5K | <0.1% | −1,880−6.1% | Reduced | Holders |
| Q1 2025 | 30,751 | $35.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 30,751 | $39.1K | <0.1% | −5,234−14.5% | Reduced | Holders |
| Q3 2024 | 35,985 | $122.7K | <0.1% | −477−1.3% | Reduced | Holders |
| Q2 2024 | 36,462 | $170.3K | <0.1% | +1,265+3.6% | Added | Holders |
| Q1 2024 | 35,197 | $261.2K | <0.1% | +6,002+20.6% | Added | Holders |
| Q4 2023 | 29,195 | $295.7K | <0.1% | +3,230+12.4% | Added | Holders |
| Q3 2023 | 25,965 | $202.5K | <0.1% | +686+2.7% | Added | Holders |
| Q2 2023 | 25,279 | $208.0K | <0.1% | +218+0.9% | Added | Holders |
| Q1 2023 | 25,061 | $181.7K | <0.1% | +7,904+46.1% | Added | Holders |
| Q4 2022 | 17,157 | $152.0K | <0.1% | +6,285+57.8% | Added | Holders |
| Q3 2022 | 10,872 | $133.0K | <0.1% | +374+3.6% | Added | Holders |
| Q2 2022 | 10,498 | $125.0K | <0.1% | −265−2.5% | Reduced | Holders |
| Q1 2022 | 10,763 | $205.0K | <0.1% | +800+8.0% | Added | Holders |
| Q4 2021 | 9,963 | $265.0K | <0.1% | +9,963 | New | Holders |